本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Amphastar Pharmaceuticals

23.56
-0.3700-1.55%
盤後23.50-0.0600-0.25%17:18 EDT
成交量:31.74萬
成交額:755.27萬
市值:11.23億
市盈率:7.70
高:24.69
開:24.40
低:23.46
收:23.93
資料載入中...
2024/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities